Explore the groundbreaking lung cancer research presented at ASCO 2015, including immunotherapy advances, targeted therapies, and precision medicine breakthroughs.
How lab-made proteins became one of our most powerful weapons in the fight against cancer. Explore the science, history, and future of monoclonal antibody therapy.
Discover how THOR-707, a novel not-alpha IL-2 therapy, combined with pembrolizumab is revolutionizing cancer immunotherapy for advanced solid tumors.
Explore the revolutionary advances in cancer chemotherapy including precision oncology, immunotherapy 2.0, and AI-driven treatment optimization in 2025.
Exploring how multifunctional polymeric nanoparticles are revolutionizing cancer immunotherapy through advanced RNA delivery systems.